19-12838590-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_014975.3(MAST1):c.18G>A(p.Trp6*) variant causes a stop gained change. The variant allele was found at a frequency of 0.00000137 in 1,457,266 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014975.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAST1 | ENST00000251472.9 | c.18G>A | p.Trp6* | stop_gained | Exon 1 of 26 | 1 | NM_014975.3 | ENSP00000251472.3 | ||
MAST1 | ENST00000591495.6 | c.71+290G>A | intron_variant | Intron 2 of 12 | 5 | ENSP00000466470.1 | ||||
MAST1 | ENST00000590883.1 | n.118G>A | non_coding_transcript_exon_variant | Exon 1 of 6 | 5 | |||||
HOOK2 | ENST00000589765.1 | n.33-12090C>T | intron_variant | Intron 1 of 3 | 5 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 exomes AF: 0.0000123 AC: 3AN: 243562Hom.: 0 AF XY: 0.00000755 AC XY: 1AN XY: 132520
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1457266Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 725080
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not provided Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has not been reported in the literature in individuals affected with MAST1-related conditions. This variant is present in population databases (rs754549142, gnomAD 0.003%). This sequence change creates a premature translational stop signal (p.Trp6*) in the MAST1 gene. It is expected to result in an absent or disrupted protein product. However, the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in MAST1 cause disease. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at